Company news
Aska Pharmaceutical Holdings Co., Ltd. (TSE:4886) news
Aska Pharmaceutical Holdings Co., Ltd. news releases on 6ix. Latest, Aug 12, 2026: Notice Concerning Completion of Payment for Disposal of Treasury Shares…
Press releases & updates
Notice Concerning Completion of Payment for Disposal of Treasury Shares as Remuneration for Restricted Shares
August 12, 2026
Summary of Consolidated Financial Results for the First Quarter of FY2026
August 4, 2026
Notice Concerning Disposal of Treasury Shares as Remuneration for Restricted Stock
July 13, 2026
Notice Regarding Results of the 5th Ordinary General Meeting of Shareholders
June 25, 2026
ASKA Pharmaceutical : May 31 2024 Licensing Agreement for Relugolix Combination Tablet for Endometriosis in the Gynecologic Disease Area
May 31, 2024
ASKA Pharmaceutical : April 25 2024 Personnel Changes of ASKA Pharmaceutical Holdings' Subsidiaries
April 25, 2024
ASKA Pharmaceutical : March 26 2024 ASKA Pharmaceutical Receives Approval for Partial Change of Manufacturing and Marketing Approval for RIFXIMA® TABLETS for Pediatric Indication
March 26, 2024
ASKA Pharmaceutical : July 20 2023 ASKA Pharmaceutical Initiates Domestic Phase I II Clinical Trial of Relugolix Combination Tablet (AKP-022)
July 20, 2023
ASKA Pharmaceutical : June 27 2023 Personnel Changes of Corporate Officers and Board Members of ASKA Pharmaceutical Holdings Subsidiaries
June 27, 2023
ASKA Pharmaceutical : June 22 2023 ASKA Pharmaceutical Files an Application for Partial Change of Manufacturing and Marketing Approval for RIFXIMA
June 21, 2023
ASKA Pharmaceutical : June 12 2023 NOTICE OF CONVOCATION OF THE 2nd ANNUAL GENERAL MEETING OF SHAREHOLDERS
June 11, 2023
ASKA Pharmaceutical : June 12 2023 Matters Subject to Measures for Electronic Provision of the Notice of the 2nd Annual General Meeting of Shareholders
June 11, 2023
ASKA Pharmaceutical : June 9 2023 ASKA Pharmaceutical Terminates Joint Research Agreement regarding the Drug Discovery Targeting Specific Ion Channels with RaQualia Pharma
June 9, 2023
ASKA Pharmaceutical : April 24 2023 ASKA Pharmaceutical Enters into a Comprehensive Business Alliance Agreement on Femtech
April 24, 2023
ASKA Pharmaceutical : April 21 2023 ASKA Pharmaceutical Holdings Installs CO₂-Free Electricity and Solar Power Generation Facilities
April 20, 2023
ASKA Pharmaceutical : April 7 2023 ASKA Pharmaceutical Terminates Option Agreement with KinoPharma regarding Cervical Dysplasia Treatment
April 6, 2023
ASKA Pharmaceutical : March 27 2023 Personnel Change of ASKA Pharmaceutical
March 27, 2023
ASKA Pharmaceutical : March 6 2023 Organizational and Personnel Changes of ASKA Pharmaceutical
March 5, 2023
ASKA Pharmaceutical : February 7 2023 EME and ASKA Announce Collaboration Agreement on Creating Novel PharmaLogical® VHH to address an unmet medical need in Obstetrics and Gynecology
February 7, 2023
ASKA Pharmaceutical : August 26 2022 Organizational and Personnel Changes of ASKA Pharmaceutical
August 25, 2022
ASKA Pharmaceutical : July 19 2022 ASKA Pharmaceutical Signs a Co-promotion Agreement with Melody International for “Fetal Monitor iCTG” in Japan
July 19, 2022
ASKA Pharmaceutical : June 28 2022 Personnel Changes of ASKA Pharmaceutical Holdings Subsidiaries
June 27, 2022